A Phase 3 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Hidradenitis Suppurativa (Initiation trial for 1 year) (2013–2014)
- Grant type:
- ABBVIE Pty Ltd
- Researchers:
-
-
- Funded by:
- ABBVIE Pty Ltd
